Physician profile
Ryan Davis
NPI 1134668379
$644.34
in general payments reported to CMS, 2019-2025
10 companies · $83.46 in 2025
The $83.46 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $208 · 2023: $285 · 2024: $67.38 · 2025: $83.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $257.99 | 2022-2025 | |
| Qol Medical, LLC | $103.12 | 2022-2025 | Sucraid |
| Regeneron Healthcare Solutions, INC. | $67.42 | 2022-2023 | Dupixent |
| Nestle Healthcare Nutrition INC. | $51.82 | 2023 | |
| Abbvie INC. | $41.19 | 2023-2025 | |
| Janssen Biotech, INC. | $40.70 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.64 | 2022-2023 | Gattex |
| Phadia US INC. | $18.25 | 2022 | |
| Intra-Sana Laboratories | $14.83 | 2024 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Endogastric Solutions, INC | $14.38 | 2023 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.